Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00813358 · ClinicalTrials.gov registry record · NA
Zenith TX2® Post-market Approval Study
A NA study, sponsored by Cook Research Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 115
- Enrollment target
NCT00813358 is a NA study that has completed, run by Cook Research Incorporated. The registered enrollment target is 115 participants.
The verdict
NCT00813358, a NA study, has completed, sponsored by Cook Research Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 115 participants
- Enrollment target
Study Summary
The Zenith TX2® Post-market Approval Study is a clinical trial approved by US FDA to further study the safety and effectiveness of the Zenith TX2® TAA Endovascular Graft in the treatment of thoracic aortic aneurysms.
Interventions
- DEVICE Zenith TX2® TAA Endovascular Graft
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2009-07-10 |
| Est. Completion | 2020-03-23 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00813358
The ClinicalTrials.gov registry entry for NCT00813358 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 115 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Cook Research Incorporated, which has 24 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Zenith TX2® TAA Endovascular Graft is the first listed.
NCT00813358 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00813358 about?
NCT00813358 is a clinical study titled "Zenith TX2® Post-market Approval Study". The Zenith TX2® Post-market Approval Study is a clinical trial approved by US FDA to further study the safety and effectiveness of the Zenith TX2® TAA Endovascular Graft in the treatment of thoracic aortic aneurysms.
What is the current status of trial NCT00813358?
This trial is currently completed. It is a NA study. The enrollment target is 115 participants. The study started on 2009-07-10. Estimated completion is 2020-03-23.
What interventions are being tested in trial NCT00813358?
The interventions under investigation include: Zenith TX2® TAA Endovascular Graft (DEVICE).
Who is sponsoring clinical trial NCT00813358?
This trial is sponsored by Cook Research Incorporated, which has 24 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.